PET Radiopharmaceuticals Market Report – Research, Industry Analysis Reports and Market Demands

Global (United States, European Union and China) PET Radiopharmaceuticals Market Research Report 2019-2025

Request for Sample of this report

Buy now

Table of Content

1 Report Overview

1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
- 1.3.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Type (2019-2025)
- 1.3.2 F-18
- 1.3.3 Ru-82
- 1.3.4 Others
1.4 Market Segment by Application
- 1.4.1 Global PET Radiopharmaceuticals Market Share by Application (2019-2025)
- 1.4.2 Oncology
- 1.4.3 Cardiology
- 1.4.4 Neurology
- 1.4.5 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends

2.1 Global PET Radiopharmaceuticals Market Size
- 2.1.1 Global PET Radiopharmaceuticals Revenue 2014-2025
- 2.1.2 Global PET Radiopharmaceuticals Sales 2014-2025
2.2 PET Radiopharmaceuticals Growth Rate by Regions
- 2.2.1 Global PET Radiopharmaceuticals Sales by Regions 2014-2019
- 2.2.2 Global PET Radiopharmaceuticals Revenue by Regions 2014-2019
2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers

3 Market Share by Manufacturers

3.1 PET Radiopharmaceuticals Sales by Manufacturers
- 3.1.1 PET Radiopharmaceuticals Sales by Manufacturers 2014-2019
- 3.1.2 PET Radiopharmaceuticals Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
- 3.2.1 PET Radiopharmaceuticals Revenue by Manufacturers (2014-2019)
- 3.2.2 PET Radiopharmaceuticals Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global PET Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.3 PET Radiopharmaceuticals Price by Manufacturers
3.4 Key Manufacturers PET Radiopharmaceuticals Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into PET Radiopharmaceuticals Market
3.6 Key Manufacturers PET Radiopharmaceuticals Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Sales and Revenue for Each Type
- 4.1.1 F-18 Sales and Revenue (2014-2019)
- 4.1.2 Ru-82 Sales and Revenue (2014-2019)
- 4.1.3 Others Sales and Revenue (2014-2019)
4.2 Global PET Radiopharmaceuticals Sales Market Share by Type
4.3 Global PET Radiopharmaceuticals Revenue Market Share by Type
4.4 PET Radiopharmaceuticals Price by Type

5 Market Size by Application

5.1 Overview
5.2 Global PET Radiopharmaceuticals Sales by Application

6 United States

6.1 United States PET Radiopharmaceuticals Breakdown Data by Company
6.2 United States PET Radiopharmaceuticals Breakdown Data by Type
6.3 United States PET Radiopharmaceuticals Breakdown Data by Application

7 European Union

7.1 European Union PET Radiopharmaceuticals Breakdown Data by Company
7.2 European Union PET Radiopharmaceuticals Breakdown Data by Type
7.3 European Union PET Radiopharmaceuticals Breakdown Data by Application

8 China

8.1 China PET Radiopharmaceuticals Breakdown Data by Company
8.2 China PET Radiopharmaceuticals Breakdown Data by Type
8.3 China PET Radiopharmaceuticals Breakdown Data by Application

9 Rest of World

9.1 Rest of World PET Radiopharmaceuticals Breakdown Data by Company
9.2 Rest of World PET Radiopharmaceuticals Breakdown Data by Type
9.3 Rest of World PET Radiopharmaceuticals Breakdown Data by Application
9.4 Rest of World PET Radiopharmaceuticals Breakdown Data by Countries
- 9.4.1 Rest of World PET Radiopharmaceuticals Sales by Countries
- 9.4.2 Rest of World PET Radiopharmaceuticals Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia

10 Company Profiles

11 Value Chain and Sales Channels Analysis

11.1 Value Chain Analysis
11.2 Sales Channels Analysis
- 11.2.1 PET Radiopharmaceuticals Sales Channels
- 11.2.2 PET Radiopharmaceuticals Distributors
11.3 PET Radiopharmaceuticals Customers

12 Market Forecast

12.1 Global PET Radiopharmaceuticals Sales and Revenue Forecast 2019-2025
12.2 Global PET Radiopharmaceuticals Sales Forecast by Type
12.3 Global PET Radiopharmaceuticals Sales Forecast by Application
12.4 PET Radiopharmaceuticals Forecast by Regions
- 12.4.1 Global PET Radiopharmaceuticals Sales Forecast by Regions 2019-2025
- 12.4.2 Global PET Radiopharmaceuticals Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
  - 14.1.1.1 Research Programs/Design
  - 14.1.1.2 Market Size Estimation
  - 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
  - 14.1.2.1 Secondary Sources
  - 14.1.2.2 Primary Sources
14.2 Author Details

Description

In 2019, the market size of PET Radiopharmaceuticals is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for PET Radiopharmaceuticals.

This report studies the global market size of PET Radiopharmaceuticals, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the PET Radiopharmaceuticals sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)

Market Segment by Product Type
F-18
Ru-82
Others

Market Segment by Application
Oncology
Cardiology
Neurology
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the PET Radiopharmaceuticals status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key PET Radiopharmaceuticals manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of PET Radiopharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025